Point72 Asia (Singapore) Pte. Ltd. 23and Me Holding Co. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in 23and Me Holding Co. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 259,027 shares of ME stock, worth $831,476. This represents 0.02% of its overall portfolio holdings.
Number of Shares
259,027
Previous 518,298
50.02%
Holding current value
$831,476
Previous $203 Million
55.61%
% of portfolio
0.02%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding ME
# of Institutions
116Shares Held
82.5MCall Options Held
404KPut Options Held
292K-
New View Capital Partners I, LLC Burlingame, CA19.5MShares$62.5 Million18.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.6MShares$50 Million0.0% of portfolio
-
Euclidean Capital LLC New York, NY10.2MShares$32.9 Million0.4% of portfolio
-
Sapphire Ventures, L.L.C. Austin, TX5.29MShares$17 Million1.93% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$15 Million0.0% of portfolio
About 23andMe Holding Co.
- Ticker ME
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 259,768,000
- Market Cap $834M
- Description
- 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...